| |
| |
| |
| |
| | | |
|
PR:Q9NQ38 | serine protease inhibitor Kazal-type 5 (human) | | | | | |
| | | | |
|
PR:Q9NQ38-1 | serine protease inhibitor Kazal-type 5 isoform f-l (human) | | | | | |
| | | | |
|
PR:Q9NQ38-3 | serine protease inhibitor Kazal-type 5 isoform long (human) | | | | | |
| | | | |
|
PR:Q9NQ38-2 | serine protease inhibitor Kazal-type 5 isoform short (human) | | | | | |
| |
| |
| | | | |
|
PR:Q9NQ38 | serine protease inhibitor Kazal-type 5 (human) | | | | | |
| | | | | |
|
PR:Q9NQ38-1 | serine protease inhibitor Kazal-type 5 isoform f-l (human) | | | | | |
| | | | | |
|
PR:Q9NQ38-3 | serine protease inhibitor Kazal-type 5 isoform long (human) | | | | | |
| | | | | |
|
PR:Q9NQ38-2 | serine protease inhibitor Kazal-type 5 isoform short (human) | | | | | |